WallStreetZenWallStreetZen

NASDAQ: RNA
Atrium Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Atrium Therapeutics earnings were -$49.5M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest RNA earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$29.1M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, RNA reported annual earnings of -$49.5M, with 97% growth. The next RNA earnings date is May 12, 2026.

RNA earnings history

Current Revenue
$18.6M
Current Earnings
-$49.5M
Current Profit Margin
-265.9%

RNA Return on Equity

Insufficient data to display

RNA Return on Assets

Current Company
-637.1%
Current Industry
-9.2%
RNA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RNA announces earnings.

RNA Return on Capital Employed

Current Company
148.42%
Current Industry
-3.2%

RNA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AARD-$57.18M-$57.59MN/A-$2.93
ABVX-$249.93M-$386.32MN/A-$5.55
ABUS-$33.04M-$33.50MN/A-$0.17
ABVC-$6.96M-$7.91MN/A-$0.39
AAPGN/A-$180.11MN/A-$2.02
View Top Biotech Stocks

RNA earnings dates

Next earnings date
May 12, 2026

Atrium Therapeutics Earnings Reports & History FAQ

What were Atrium Therapeutics's earnings last quarter?

On RNA's earnings call on Invalid Date, Atrium Therapeutics (NASDAQ: RNA) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total RNA earnings for the quarter were -$29.14 million. In the same quarter last year, Atrium Therapeutics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Atrium Therapeutics stock.

When does Atrium Therapeutics report earnings?

The next RNA earnings date is Invalid Date. Add RNA to your watchlist to be reminded of Atrium Therapeutics's next earnings date.

Is Atrium Therapeutics profitable or losing money?

As of the last Atrium Therapeutics earnings report, Atrium Therapeutics is currently losing money. Atrium Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$49.50 million, a 97.04% increase year over year.

What was RNA's earnings growth in the past year?

As of Atrium Therapeutics's earnings date in Invalid Date, Atrium Therapeutics's earnings has grown year over year. RNA earnings in the past year totalled -$49.50 million.

What are Atrium Therapeutics's earnings expectations?

The current EPS estimate for Atrium Therapeutics's earnings report in Invalid Date is -$1.28.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.